BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 27083401)

  • 1. Use of monoclonal antibodies to detect specific mutations in formalin-fixed, paraffin-embedded tissue sections.
    Guo Z; Lloyd RV
    Hum Pathol; 2016 Jul; 53():168-77. PubMed ID: 27083401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRAF V600 mutations in Langerhans cell histiocytosis with a simple and unique assay.
    Tatsuno M; Shioda Y; Iwafuchi H; Yamazaki S; Iijima K; Takahashi C; Ono H; Uchida K; Okamura O; Matubayashi M; Okuyama T; Matsumoto K; Yoshioka T; Nakazawa A
    Diagn Pathol; 2016 Apr; 11():39. PubMed ID: 27094161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-resolution melting analysis as a sensitive prescreening diagnostic tool to detect KRAS , BRAF , PIK3CA , and AKT1 mutations in formalin-fixed, paraffin-embedded tissues.
    Ney JT; Froehner S; Roesler A; Buettner R; Merkelbach-Bruse S
    Arch Pathol Lab Med; 2012 Sep; 136(9):983-92. PubMed ID: 22938585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of SYT-SSX mutant transcripts in formalin-fixed paraffin-embedded sarcoma tissues using one-step reverse transcriptase real-time PCR.
    Norlelawati AT; Mohd Danial G; Nora H; Nadia O; Zatur Rawihah K; Nor Zamzila A; Naznin M
    Malays J Pathol; 2016 Apr; 38(1):11-8. PubMed ID: 27126659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel liquidchip platform for simultaneous detection of 70 alleles of DNA somatic mutations on EGFR, KRAS, BRAF and PIK3CA from formalin-fixed and paraffin-embedded slides containing tumor tissue.
    Li G; Luo X; He J; Zhu Z; Yu G; Qin H; Zeng T; Liu Z; Wu S; Xu J; Ren-Heidenreich L
    Clin Chem Lab Med; 2011 Feb; 49(2):191-5. PubMed ID: 21118047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-center real-world comparison of the fully automated Idylla™ microsatellite instability assay with routine molecular methods and immunohistochemistry on formalin-fixed paraffin-embedded tissue of colorectal cancer.
    Velasco A; Tokat F; Bonde J; Trim N; Bauer E; Meeney A; de Leng W; Chong G; Dalstein V; Kis LL; Lorentzen JA; Tomić S; Thwaites K; Putzová M; Birnbaum A; Qazi R; Primmer V; Dockhorn-Dworniczak B; Hernández-Losa J; Soares FA; Gertler AA; Kalman M; Wong C; Carraro DM; Sousa AC; Reis RM; Fox SB; Fassan M; Brevet M; Merkelbach-Bruse S; Colling R; Soilleux E; Teo RYW; D'Haene N; Nolet S; Ristimäki A; Väisänen T; Chapusot C; Soruri A; Unger T; Wecgowiec J; Biscuola M; Frattini M; Long A; Campregher PV; Matias-Guiu X
    Virchows Arch; 2021 May; 478(5):851-863. PubMed ID: 33170334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody validation by combining immunohistochemistry and protein extraction from formalin-fixed paraffin-embedded tissues.
    Schuster C; Malinowsky K; Liebmann S; Berg D; Wolff C; Tran K; Schott C; Reu S; Neumann J; Faber C; Höfler H; Kirchner T; Becker KF; Hlubek F
    Histopathology; 2012 May; 60(6B):E37-50. PubMed ID: 22393911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Will PAXgene substitute formalin? A morphological and molecular comparative study using a new fixative system.
    Belloni B; Lambertini C; Nuciforo P; Phillips J; Bruening E; Wong S; Dummer R
    J Clin Pathol; 2013 Feb; 66(2):124-35. PubMed ID: 23125305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation detection in formalin-fixed prostate cancer biopsies taken at the time of diagnosis using next-generation DNA sequencing.
    Manson-Bahr D; Ball R; Gundem G; Sethia K; Mills R; Rochester M; Goody V; Anderson E; O'Meara S; Flather M; Keeling M; Yazbek-Hanna M; Hurst R; Curley H; Clark J; Brewer DS; McDermott U; Cooper C
    J Clin Pathol; 2015 Mar; 68(3):212-7. PubMed ID: 25586381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A method to generate antigen-specific mAb capable of staining formalin-fixed, paraffin-embedded tissue sections.
    Wang X; Campoli M; Cho HS; Ogino T; Bandoh N; Shen J; Hur SY; Kageshita T; Ferrone S
    J Immunol Methods; 2005 Apr; 299(1-2):139-51. PubMed ID: 15896802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative real-time polymerase chain reaction is an alternative method for the detection of HER-2 amplification in formalin-fixed paraffin-embedded breast cancer samples.
    Pu T; Guo P; Qiu Y; Chen S; Yang L; Sun L; Ye F; Bu H
    Int J Clin Exp Pathol; 2015; 8(9):10565-74. PubMed ID: 26617766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality control material for the detection of somatic mutations in fixed clinical specimens by next-generation sequencing.
    Dumur CI; Almenara JA; Powers CN; Ferreira-Gonzalez A
    Diagn Pathol; 2015 Sep; 10():169. PubMed ID: 26376646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fractin immunostaining for the detection of apoptotic cells and apoptotic bodies in formalin-fixed and paraffin-embedded tissue.
    Suurmeijer AJ; van der Wijk J; van Veldhuisen DJ; Yang F; Cole GM
    Lab Invest; 1999 May; 79(5):619-20. PubMed ID: 10334574
    [No Abstract]   [Full Text] [Related]  

  • 14. Making the most of pathological specimens: molecular diagnosis in formalin-fixed, paraffin embedded tissue.
    Fairley JA; Gilmour K; Walsh K
    Curr Drug Targets; 2012 Nov; 13(12):1475-87. PubMed ID: 22974391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of new rabbit monoclonal antibody to estrogen receptor: immunohistochemical assessment on formalin-fixed, paraffin-embedded tissue sections.
    Huang Z; Zhu W; Szekeres G; Xia H
    Appl Immunohistochem Mol Morphol; 2005 Mar; 13(1):91-5. PubMed ID: 15722800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer Recurrence.
    Ignatiadis M; Azim HA; Desmedt C; Veys I; Larsimont D; Salgado R; Lyng MB; Viale G; Leyland-Jones B; Giobbie-Hurder A; Kammler R; Dell'Orto P; Rothé F; Laïos I; Ditzel HJ; Regan MM; Piccart M; Michiels S; Sotiriou C
    JAMA Oncol; 2016 Feb; 2(2):217-24. PubMed ID: 26633571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of evaluation of DNA amplificability in KRAS mutation testing with dideoxy sequencing using formalin-fixed and paraffin-embedded colorectal cancer tissues.
    Okayama N; Nishioka M; Hazama S; Sakai K; Suehiro Y; Maekawa M; Sakamoto J; Iwamoto S; Kato T; Mishima H; Oka M; Hinoda Y
    Jpn J Clin Oncol; 2011 Feb; 41(2):165-71. PubMed ID: 20926413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescence in situ analysis of soft tissue tumor associated genetic alterations in formalin-fixed paraffin-embedded tissue.
    Horn H; Allmanritter J; Doglioni C; Marx A; Müller J; Gattenlöhner S; Staiger AM; Rosenwald A; Ott G; Ott MM
    Pathol Res Pract; 2014 Dec; 210(12):804-11. PubMed ID: 25446247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of a fully automated high-throughput DNA extraction method from formalin-fixed, paraffin-embedded tissue for KRAS, and BRAF somatic mutation analysis.
    van Eijk R; Stevens L; Morreau H; van Wezel T
    Exp Mol Pathol; 2013 Feb; 94(1):121-5. PubMed ID: 22750048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferating cell nuclear antigen counts in formalin-fixed paraffin-embedded tissue correlate with Ki-67 in fresh tissue.
    Dervan PA; Magee HM; Buckley C; Carney DN
    Am J Clin Pathol; 1992 May; 97(5 Suppl 1):S21-8. PubMed ID: 1349455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.